Here you are Bionaturis’ latest news

 

 

Imagen Bionaturis Newsletter

IN THIS ISSUE

  • Eduard Punset: “Bionaturis is able to deliver hope throughout innovation”
  • Roche and Oryzon, a historic agreement for Spanish Biotechnology
  • “Do your best to respect yourself and the others. Keep informed and learn to communicate”

Let’s get to know…

Juan Jose Infante Viñolo, 40 years old, born in La Linea de la Concepcion (Cadiz). PhD in Sciences at Cadiz University.

 

Juan José Infante

  • -When you were a child, what did you want to be as an adult?
  • Well, I wanted to become an adult. And learn a lot on the way.
  • -What do you like the most about your job?
  • Learning every day about Biotechnology. And teaching.
  • -What are your future challenges?
  • Making progress in my profesional career, developing more the business field. And doing it reaching agreements for the development of Bionaturis’ products.
  • -Your favourite dish
  • Bread and Nutella for breakfast. I can’t live without it.
  • -A place
  • Seattle. This place has marked a milestone in my life.
  • -A film
  • ‘La Grande Bellezza’, by Paolo Sorrentino. I will watch it every birthday from now on.
  • -A historical figure
  • For being balanced and in this current context, I think that Nelson Mandela taught the way and manners.
  • -A book
  • ‘The Wind-Up Bird Chronicle’, by Haruki Murakami.
  • -A song
  • ‘Manhattan’, from the record ‘Omega’, by Enrique Morente. It’s a version of ‘First we take Manhattan’, by Leonard Cohen.
  • -What do you usually do in your free time?
  • Reading about Biotechnology. I am such as those freaks.
  • -A proposal to get rid of the crisis
  • We must ask ourselves at each moment if what we are doing has sense. And we must ask the same to everybody. We shouldn’t let anything get by one. Or only a few.
  • -How do you imagine the world in 20 years?
  • With more tolerant and prudent people. And using more Biotechnology, of course.
 Juan Jose has been working as Bionaturis CSO since March 2007.

Eduard Punset: “Bionaturis is able to deliver hope throughout innovation”

Bionaturis has been honored by the visit of the well-known lawyer, economist and science writer Eduard Punset, who has known at firsthand how cutting-edge biological drugs can be obtained using butterfly caterpillars as living bioreactors. They have gone over Bionaturis’ facilities being introduced to the unique features of the FLYLIFE platform, one of the industrial-scale system of biodrug manufacturing with a highest yield per square meter on the market and an obvious example of disruptive innovation[...] Read more

Roche and Oryzon, a historic agreement for Spanish Biotechnology

Roche has bought the rights to an experimental drug from Spain’s Oryzon Genomics that can switch on genes to block cancer growth, as the Swiss drugmaker looks to maintain its dominance in the lucrative field of oncology. The world’s largest maker of cancer drugs will pay Barcelona-based Oryzon $21 million in upfront and near-term milestone payments and could pay out more than $500 million if the company meets other goals. The deal will give Roche rights to Oryzon’s experimental drug ORY-1001 which was granted orphan drug status by European health regulators last year and is currently in early-stage clinical testing for acute myeloid leukaemia [...] Read more

 

“Do your best to respect yourself and the others.
Keep informed and learn
to communicate”

Communication, respect and a never-ending eager to learn are the cornerstones of the second point of the Decalogue about the executive role written by Juan José Almagro, president of Bionaturis.
[...] Read more

 

INVESTOR INFO

Relevant Info: Capital IncreaseRelevant Info: Publication on the BormeRelevant Info: Document of Capital Increase
Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis

 

Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto?    No quiero seguir recibiendo este newsletter    Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|**|REWARDS|*